Employment and income among first-time cases diagnosed with non-affective psychosis in Stockholm, Sweden: a follow-up study 2004/2005-2010

Social Psychiatry and Psychiatric Epidemiology
Johanna FalkLotta Nylén


Non-affective psychoses (F20-F29) are serious conditions causing a high degree of disability. Loss of income and increasing costs for personal care and treatment are severe consequences following the disorders, but less is known about employment and income in different social strata. The aim was to study these conditions among persons with non-affective psychosis compared to the general population, and possible social differentials. A population-based follow-up study with 530,350 persons (aged 18-44), including 756 first-time cases diagnosed with non-affective psychosis registered in in- or outpatient psychiatric care in 2005 or 2006. Age-standardised rates of non-employment, disability pension, social assistance and poverty were calculated at baseline and at follow-up in 2010. Odds ratios of poverty were estimated using logistic regression, adjusting for employment status, age, education and country of birth. Before diagnosis, rates of non-employment, disability pension and social assistance were higher among persons with non-affective psychosis compared to the general population. At the follow-up, rates of disability pension had doubled, most pronounced among women with only compulsory education. Rates of social assistance we...Continue Reading


Jul 1, 1987·British Medical Bulletin·P J Taylor
Dec 1, 1974·Journal of Health and Social Behavior·William W Eaton
Dec 8, 2000·International Journal of Health Services : Planning, Administration, Evaluation·Bo BurströmFinn Diderichsen
Oct 24, 2002·Social Psychiatry and Psychiatric Epidemiology·Ch DalmanP Allebeck
Dec 26, 2002·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Elliot M GoldnerJulian M Somers
Jan 24, 2003·International Journal of Epidemiology·Steinar KrokstadSteinar Westin
Jan 7, 2004·Archives of General Psychiatry·Esben AgerboPreben Bo Mortensen
Mar 31, 2004·Social Psychiatry and Psychiatric Epidemiology·Majella ByrnePreben Bo Mortensen
Jul 6, 2004·Epidemiologic Reviews·Carles MuntanerPatricia O'Campo
May 27, 2005·PLoS Medicine·Sukanta SahaJohn McGrath
Jun 1, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Wulf RösslerAnita Riecher-Rössler
Sep 2, 2005·The American Journal of Psychiatry·S WicksChristina Dalman
Apr 20, 2007·Schizophrenia Bulletin·Shirli WernerJonathan Rabinowitz
Apr 9, 2008·Comprehensive Psychiatry·Augusto CastagniniGerman E Berrios
May 16, 2008·Epidemiologic Reviews·John McGrathJoy Welham
Jul 8, 2008·Social Psychiatry and Psychiatric Epidemiology·Maria MattssonYvonne Forsell
Jun 17, 2011·The American Journal of Psychiatry·Evelyn J BrometSu-wei Chang
Aug 17, 2011·International Journal of Health Services : Planning, Administration, Evaluation·Paula HollandMargaret Whitehead
Oct 24, 2012·Schizophrenia Bulletin·Simona A StiloCraig Morgan

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Nodding Syndrome

Nodding Syndrome is a neurological and epileptiform disorder characterized by psychomotor, mental, and growth retardation. Discover the latest research on Nodding Syndrome here.

LRRK2 & Microtubules

Mutations in the LRRK2 gene are risk-factors for developing Parkinson’s disease (PD). LRRK2 mutations in PD have been shown to enhance its association with microtubules. Here is the latest research.